Mathias Schlegel, Bruno Coutard, Eric M. Leroy, Alexander C. Adam, René Kallies, Thijs Kuiken, Rainer G. Ulrich, Alvaro Aguilar Setién, Anatoly P. Gmyl, Stefan M. Klose, Christian Drosten, Bernd Hoffmann, Supaporn Wacharapluesadee, Marcel A. Müller, Florian Gloza-Rausch, Sonja Matthee, Jan Felix Drexler, Lonneke M. Leijten, Chantal B.E.M. Reusken, Veronika M. Cottontail, Daniel Rupp, Klaus Osterrieder, Jonas Schmidt-Chanasit, Tabea Binger, Beate M. Kümmerer, Thiravat Hemachudha, Yaw Adu-Sarkodie, Victor M. Corman, Ralf Bartenschlager, Detlev H. Krüger, Debby van Riel, Samuel Oppong, Alexander N. Lukashev, Daniel Ritz, Martin Beer, Mathieu Bourgarel, A. P. Annan, Institute of Virology, University of Bonn Medical Centre, Sechenov First Moscow State Medical University, Architecture et fonction des macromolécules biologiques (AFMB), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA), University of Cologne, Department of Viroscience, Erasmus University Medical Center [Rotterdam] (Erasmus MC), University of Ulm (UUlm), Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kwame Nkrumah University of Science and Technology [GHANA] (KNUST), Centre de Coopération Internationale en Recherche Agronomique pour le Développement (Cirad), Heidelberg University, Friedrich Löffler Institute - Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Institute of Medical Virology (Helmut Ruska Haus), Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin, Bernhard Nocht Institute for Tropical Medicine - Bernhard-Nocht-Institut für Tropenmedizin [Hamburg, Germany] (BNITM), Instituto Mexicano del Seguro Social [Mexico City, Mexico] (IMSS), Chulalongkorn University [Bangkok], Free University of Berlin (FU), Department of Infectious Diseases [Heidelberg, Germany], Heidelberg University Hospital [Heidelberg], Department of Conservation Ecology and Entomology, Stellenbosch University, Institut of Diagnostic Virology, Department of Viroscience [Rotterdam, The Netherlands], Netherlands Center for Infectious Disease Control, Centre International de Recherches Médicales de Franceville (CIRMF), Zoonoses virales et MTN (MIVEGEC-VIROZ), Biologie des infections virales: Emergence, DIFfusion, Impact, Contrôle, Elimination (EDIFICE), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), University of Bonn, Virology, Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Kwame Nkrumah University of Science and Technology (KNUST), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), Universität Bonn = University of Bonn, Bernhard Nocht Institut for Tropical Medicine, Centre International de Recherches Médicales de Franceville, and Institut de Recherche pour le Développement (IRD [France-Sud])-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
Hepatitis C virus (HCV) is among the most relevant causes of liver cirrhosis and hepatocellular carcinoma. Research is complicated by a lack of accessible small animal models. The systematic investigation of viruses of small mammals could guide efforts to establish such models, while providing insight into viral evolutionary biology. We have assembled the so-far largest collection of small-mammal samples from around the world, qualified to be screened for bloodborne viruses, including sera and organs from 4,770 rodents (41 species); and sera from 2,939 bats (51 species). Three highly divergent rodent hepacivirus clades were detected in 27 (1.8%) of 1,465 European bank voles (Myodes glareolus) and 10 (1.9%) of 518 South African four-striped mice (Rhabdomys pumilio). Bats showed anti-HCV immunoblot reactivities but no virus detection, although the genetic relatedness suggested by the serologic results should have enabled RNA detection using the broadly reactive PCR assays developed for this study. 210 horses and 858 cats and dogs were tested, yielding further horse-associated hepaciviruses but none in dogs or cats. The rodent viruses were equidistant to HCV, exceeding by far the diversity of HCV and the canine/equine hepaciviruses taken together. Five full genomes were sequenced, representing all viral lineages. Salient genome features and distance criteria supported classification of all viruses as hepaciviruses. Quantitative RT-PCR, RNA in-situ hybridisation, and histopathology suggested hepatic tropism with liver inflammation resembling hepatitis C. Recombinant serology for two distinct hepacivirus lineages in 97 bank voles identified seroprevalence rates of 8.3 and 12.4%, respectively. Antibodies in bank vole sera neither cross-reacted with HCV, nor the heterologous bank vole hepacivirus. Co-occurrence of RNA and antibodies was found in 3 of 57 PCR-positive bank vole sera (5.3%). Our data enable new hypotheses regarding HCV evolution and encourage efforts to develop rodent surrogate models for HCV., Author Summary The hepatitis C virus (HCV) is one of the most relevant causes of liver disease and cancer in humans. The lack of a small animal models represents an important hurdle on our way to understanding, treating, and preventing hepatitis C. The investigation of small mammals could identify virus infections similar to hepatitis C in animals that can be kept in laboratories, such as rodents, and can also yield insights into the evolution of those ancestral virus lineages out of which HCV developed. Here, we investigated a worldwide sample of 4,770 rodents, 2,939 bats, 210 horses and 858 cats and dogs for HCV-related viruses. New viruses were discovered in European bank voles (Myodes glareolus) and South African four-striped mice (Rhabdomys pumilio). The disease in bank voles was studied in more detail, suggesting that infection of the liver occurs with similar symptoms to those caused by HCV in humans. These rodents might thus enable the development of new laboratory models of hepatitis C. Moreover, the phylogenetic history of those viruses provides fascinating new ideas regarding the evolution of HCV ancestors.